Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

Similar articles for PubMed (Select 19213687)

1.

Not an HIV cure, but encouraging new directions.

Levy JA.

N Engl J Med. 2009 Feb 12;360(7):724-5. doi: 10.1056/NEJMe0810248. No abstract available.

PMID:
19213687
2.

Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.

Hütter G, Nowak D, Mossner M, Ganepola S, Müssig A, Allers K, Schneider T, Hofmann J, Kücherer C, Blau O, Blau IW, Hofmann WK, Thiel E.

N Engl J Med. 2009 Feb 12;360(7):692-8. doi: 10.1056/NEJMoa0802905.

3.

Seeking a cure for AIDS.

Laurence J.

AIDS Read. 2008 May;18(5):228, 234. No abstract available.

PMID:
18589476
4.

Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy.

Bai J, Rossi J, Akkina R.

AIDS Res Hum Retroviruses. 2001 Mar 20;17(5):385-99.

PMID:
11282007
5.

CCR5 as target for HIV-1 gene therapy.

Nazari R, Joshi S.

Curr Gene Ther. 2008 Aug;8(4):264-72. Review.

PMID:
18691022
6.

[HIV: vision of a cure].

Boffi el Amari E.

Rev Med Suisse. 2011 Oct 12;7(312):1968, 1970-3. French.

PMID:
22097447
7.
8.

Allogeneic transplantation of CCR5-deficient progenitor cells in a patient with HIV infection: an update after 3 years and the search for patient no. 2.

Hütter G, Thiel E.

AIDS. 2011 Jan 14;25(2):273-4. doi: 10.1097/QAD.0b013e328340fe28. No abstract available.

PMID:
21173593
9.

XVI International AIDS Conference. New drug classes from Toronto. Plus some older ones.

Sharp M.

Posit Aware. 2006 Nov-Dec;17(6):16-7. No abstract available.

PMID:
17233084
10.

Optimization of ex vivo activation and expansion of macaque primary CD4-enriched peripheral blood mononuclear cells for use in anti-HIV immunotherapy and gene therapy strategies.

Zhang D, Murakami A, Johnson RP, Sui J, Cheng J, Bai J, Marasco WA.

J Acquir Immune Defic Syndr. 2003 Mar 1;32(3):245-54.

PMID:
12626883
12.

Report from the XVI International AIDS Conference. CCR5 inhibitors.

Feinberg J.

AIDS Clin Care. 2006 Nov;18(11):100-1. No abstract available.

PMID:
17186581
13.

Can HIV be cured with stem cell therapy?

Deeks SG, McCune JM.

Nat Biotechnol. 2010 Aug;28(8):807-10. doi: 10.1038/nbt0810-807. No abstract available.

PMID:
20697404
14.

T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.

Swan CH, Bühler B, Steinberger P, Tschan MP, Barbas CF 3rd, Torbett BE.

Gene Ther. 2006 Oct;13(20):1480-92. Epub 2006 Jun 1. Erratum in: Gene Ther. 2007 Apr;14(7):626. Steinberger, P [added].

PMID:
16738691
15.

Anti-HIV agents. Receptor blocker (SCH 532706) enters clinical trials.

[No authors listed]

TreatmentUpdate. 2008 Mar;20(2):8-9. No abstract available.

PMID:
18663778
16.

A novel chemokine-receptor-5 (CCR5) blocker, SCH532706, has differential effects on CCR5+CD4+ and CCR5+CD8+ T cell numbers in chronic HIV infection.

Pett SL, Zaunders J, Bailey M, Murray J, MacRae K, Emery S, Cooper DA, Kelleher AD.

AIDS Res Hum Retroviruses. 2010 Jun;26(6):653-61. doi: 10.1089/aid.2009.0278.

PMID:
20560795
17.

Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infection.

Oswald-Richter K, Grill SM, Leelawong M, Tseng M, Kalams SA, Hulgan T, Haas DW, Unutmaz D.

PLoS Pathog. 2007 Apr;3(4):e58.

18.

Long-term safety study of vicriviroc presented.

[No authors listed]

Proj Inf Perspect. 2008 Dec;(47):13. No abstract available.

PMID:
19227564
19.

Novel targets for antiretroviral therapy: clinical progress to date.

Dau B, Holodniy M.

Drugs. 2009;69(1):31-50. doi: 10.2165/00003495-200969010-00003. Review.

PMID:
19192935
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk